Virology’s cover photo
Virology

Virology

Pharmaceutical Manufacturing

We are committed to furthering innovation of care for HIV and HCV through science and partnership.

About us

Follow us here on LinkedIn for global news and updates on the work being done to advance the science and understanding of HIV and AbbVie’s HCV elimination efforts. We believe that we all have our own part to play in making HCV elimination the next public health story, and forming transformative partnerships is essential to helping solve some of the most pressing challenges for the HCV community.

Industry
Pharmaceutical Manufacturing
Company size
10,001+ employees

Updates

  • Did you know: #HepatitisC increases the risk of #LiverCancer? The tools to eliminate #HCV exist, but action is needed to increase testing and treatment services around the world. On #WorldHepatitisDay, join us and The World Hepatitis Alliance in raising awareness of the impact of HCV and the importance of advancing care in the global community: https://bit.ly/4lI1VH8 [Video description: Interview with Rachel Halford, President of World Hepatitis Alliance & former HCV patient. On-screen text reads, “Achieving HCV elimination goals would avert 1.5 million deaths from HCV alone over the next decade. Join us in helping move the world closer to eliminating Hepatitis C.”]

  • As we wrap up at #EASLCongress 2025, we’re more energized than ever to achieve #HepatitisC elimination and close gaps in care. Read more on how we can work together toward #HCV elimination goals in POLITICO Studio: https://politi.co/3GNIq0p [Video description: Rachel Halford, President of the World Hepatitis Alliance says, “My hope for the future of HCV is that we achieve the WHO’s global goal to eliminate the disease by 2030. We have all the tools, information, and global policies to do so, we just need to focus our collective efforts toward this goal and leave no one behind.”]

  • #HepatitisC is one of the major risk factors for #LiverCancer, so early detection, testing and treatment of this disease is critical. Tomorrow marks the first day of #EASLCongress 2025, where we're highlighting the socioeconomic impact of #HCV and how global leaders are working together to eliminate the disease. Learn more. ⬇ [Video description: An interview with Homie Razavi, Managing Director, Centers Disease Analysis Foundation. On-screen text reads, “Scaling up Hepatitis C testing and treatment can save the world $23 billion in productivity losses, reduce healthcare spending and prevent an estimated 10 million new infections worldwide. Join us in the movement to eliminate Hepatitis C.”]

  • #LiverCancer is the sixth most common cancer worldwide, and approximately 20% of liver cancer diagnoses are caused by #hepatitisC. On #WorldLiverDay, learn about our commitment to advancing care in the global #HCV community and help eliminate the disease by 2030: https://politi.co/4il5UH1 [Video description: Mudra Kapoor, M.D., VP, Global Medical Affairs, Specialty & Global Medical Operations, Medical Affairs + Health Impact, AbbVie, says, “The WHO’s goal to eliminate HCV by 2030 is extremely motivational, but more needs to be done. Without patients getting screened and treated, we won't eliminate this disease – something we have the tools to do and is in our grasp.”]

  • Did you know that #HepatitisC is one of the major risk factors of #LiverCancer? This month we’re recognizing #LiverCancerAwarenessMonth, raising awareness of these diseases and the potential impact of reaching the World Health Organization’s goal to eliminate #HCV by 2030. Learn more from The World Hepatitis Alliance: https://bit.ly/4071j62 [Video description: Interview with John Ward, Director, Coalition for Global Hepatitis Elimination. On-screen text reads, “More than 800,000 people worldwide are diagnosed with liver cancer each year. We estimate that by 2030, if we achieve hepatitis C elimination goals, we can avert over two million deaths from liver disease, including liver cancer. Join us as we work to help eliminate Hepatitis C.”]

  • #LiverCancer is the sixth most common cancer worldwide, and #HepatitisC is one of the major risk factors. During #LiverCancerAwarenessMonth, we’re raising awareness of these diseases and the importance of early diagnosis and care to reach the World Health Organization’s goal of #HCV elimination by 2030. [Video description: An interview with Danjuma Adda, past president of The World Hepatitis Alliance & Founder of the Centre for Initiative and Development (CFID) Taraba. On-screen text reads, “For HCV, early diagnosis and access to care can help avoid serious complications of liver disease. Early detection saves lives and the majority of people with liver cancer are diagnosed too late, especially in sub-Saharan Africa. We are committed to improving the lives of people living with Hepatitis C.”]

  • #LiverCancer is the sixth most common cancer worldwide, and #HepatitisC is one of the major risk factors. With prevention, testing and treatment services available around the world, #HepatitisC elimination by 2030 is within reach. October is #LiverCancerAwarenessMonth and we’re raising awareness of #LiverCancer and #HCV. Learn more ⬇ [Video description: An interview with Homie Razavi, Managing Director, Center for Disease Analysis Foundation. On-screen text reads, “Scaling up Hepatitis C testing and treatment can save the world $23 billion in productivity losses, reduce healthcare spending and prevent an estimated 10 million new infections worldwide. Join us in the movement to eliminate Hepatitis C.”]

  • #LiverCancer is the sixth most common cancer worldwide, and approximately 20% of liver cancer diagnoses are caused by #HepatitisC. Learn more about #HCV’s global impact and how we can act now to help eliminate the disease by 2030 in POLITICO Studio: https://politi.co/4e7Oz3b [Video description: Interview with John Ward, Director, Global Coalition for Hepatitis Elimination. On-screen text reads, “More than 800,000 people worldwide are diagnosed with liver cancer each year. We estimate that by 2030, if we achieve hepatitis C elimination goals, we can avert over two million deaths from liver disease, including liver cancer. Join us as we work to help eliminate Hepatitis C.”]

  • By scaling up #HepatitisC testing and treatment, an estimated 10 million new infections can be prevented worldwide. Join us and our global partners at this year’s European HCV Elimination Summit to hear Limas Kupcinskas with the Lithuanian HCV Elimination Working Group discuss Lithuania’s improved screening program and how it can serve as an example for other countries in their efforts to help eliminate the disease by 2030.

    • On screen text reads: “European HCV Elimination Summit. Vilnius, Lithuania. September 19, 2024.”
  • If we all work together, we can improve #HepatitisC testing and treatment programs around the world. Learn about our commitment to advancing care in the global #HCV community and help eliminate the disease by 2030 in our article with POLITICO Studio: https://politi.co/3Zlp4qv [Video description: Mudra Kapoor, M.D., VP, Global Medical Affairs, Specialty & Global Medical Operations, AbbVie, says, “The WHO’s goal to eliminate HCV by 2030 is extremely motivational, but more needs to be done. Without patients getting screened and treated, we won't eliminate this disease – something we have the tools to do and is in our grasp.”]

Affiliated pages

Similar pages